We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Heavy Cannabis Use Tied to IQ Decline

By HospiMedica International staff writers
Posted on 11 Sep 2012
People repeatedly diagnosed with cannabis dependence during young adulthood had noticeable declines in IQ scores by age 38, especially when the heavy use started in their teens, according to a new study.

Researchers at Duke University (Durham, NC, USA), King’s College London (United Kingdom), and other institutions, conducted a study was to test the association between persistent cannabis use and neuropsychological decline. More...
The participants were members of the Dunedin (New Zealand) Study, a prospective study of a birth cohort of 1,037 individuals followed from birth in 1972/1973 to age 38. Cannabis use was ascertained in interviews at ages 18, 21, 26, 32, and 38. Neuropsychological testing was conducted at age 13, before initiation of cannabis use, and again at age 38, after a pattern of persistent cannabis use had developed.

The results showed that 242 people never reported cannabis use, nor were they ever diagnosed with dependence; 479 indicated some use but never received a diagnosis; and 80, 35, and 38 had received one, two, or three or more dependence diagnoses in the adult evaluations. In the small group of participants who became cannabis dependent before age 18--a total of 23 cohort members-- the decline translated to an average decline of about 8 IQ points, whereas 14 participants who also showed heavy cannabis use but only beginning in adulthood showed only a very small drop in full-scale scores. The study was published on July 30, 2012, in the Proceedings of the National Academy of Sciences of the USA (PNAS).

“Collectively, findings are consistent with speculation that cannabis use in adolescence, when the brain is undergoing critical development, may have neurotoxic effects,” concluded lead author Madeline Meier, PhD, of Duke, and colleagues. “Prevention and policy efforts should focus on delivering to the public the message that cannabis use during adolescence can have harmful effects on neuropsychological functioning, delaying the onset of cannabis use at least until adulthood, and encouraging cessation of cannabis use particularly for those who began using cannabis in adolescence.”

Related Links:

Duke University
King’s College London



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Mammo DR Retrofit Solution
DR Retrofit Mammography
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.